Response of Aerobic Capacity to Low-Level Laser Therapy in Burned Patients.

Severe burns lead to decreased pulmonary function and impaired aerobic capacity for long periods postinjury. Low-level laser therapy is a modality used to improve aerobic capacity, enhance exercise performance, and increase the time until fatigue when used before aerobic exercises. This work aims to determine the impacts of pre-exercise low-level laser therapy on aerobic capacity in burn cases. Sixty adults burned cases of both sex, aged from 25 to 40 years, with second-degree healed thermal burns, and the total burned body surface area ranged from 20 to 40% participated in this study after complete wound healing. They were randomly categorized into two groups of equal numbers. The study group received low-level laser therapy before aerobic exercises, three sessions per week for 12 weeks, while the control group performed aerobic exercises three times weekly for 12 weeks. All cases received the routine physical treatment program. Aerobic capacity was assessed for both groups by measuring maximum oxygen consumption and time to exhaustion at baseline and 12 weeks following interventions. There was a statistically significant rise in the mean values of maximum oxygen usage and time to fatigue after 12 weeks of treatment in both groups. However, after comparison, the improvements in the study group were statistically significant than those in the control group with P < .01 and P < .05, respectively. Low-level laser therapy has a beneficial therapeutic impact on promoting aerobic capacity, improving maximum oxygen consumption, and increasing treadmill time in burned cases when preceding aerobic exercises.

Association of VDBP rs4701 Variant, but not VDR/RXR-α Over-Expression with Bone Mineral Density in Pediatric Well-Chelated ß-Thalassemia Patients.

BACKGROUND: The reduced rate of bone formation despite the availability of vitamin D has been reported in ß-thalassemia. Genetic factors, together with environmental ones, could be implicated in this condition. Since vitamin D binding protein (VDBP) maintains bioavailability of vitamin D which binds to vitamin D receptor (VDR)-retinoid X receptor alpha (RXRA) heterodimer to exert its molecular actions, we speculated that vitamin D metabolic-axis expression signature and variants could be potential molecular candidates for bone turnover/disease in thalassemia. To this end, this study aims to analyze VDR/RXRA expression signature, and two VDBP variants in a pilot sample of Egyptian ß-thalassemia children in correlation with bone mineral density (BMD). PATIENTS AND METHODS: Forty-four well-chelated ß-thalassemia children and 40 unrelated controls were enrolled. The serum bone chemistry profile was measured. Peripheral blood mononuclear cells (PBMN) VDR/RXRA expression levels were quantified by Real-Time quantitative reverse transcription-polymerase chain reaction (qRT-PCR). VDBP rs7041 and rs4588 variants were identified by Real-Time allelic discrimination assay. All patients were subjected to lumbar-spine Dual-energy X-ray absorptiometry (DEXA). RESULTS: VDR/RXRA expressions were significantly higher in ß-thalassemia children compared to controls (P = 0.001 and <0.001, respectively) and showed higher values in ß-thalassemia major relative to ß-thalassemia intermedia. Expression levels of both genes were not associated with sex or BMD. However, VDBP rs4701 genotyping revealed lower BMD-L4 and a higher frequency of osteoporosis. CONCLUSIONS: ß-Thalassemia children had higher expression levels of PBMN VDR/RXRA. VDBP rs4701 variant was associated with osteoporosis in our ß-thalassemia patients on vitamin D supplementation. Further large-scale studies in other ethnic populations are warranted.

Endophytic fungi from the medicinal herb Euphorbia geniculata as a potential source for bioactive metabolites.

Many researchers proved that plant endophytes manage successful issues to synthesize active chemicals within plant cells. These bioactive compounds might support a range of plant defense mechanism against many pathogenic microorganisms. In this study, a total of 22 isolates representing 21 fungal species belonging to 15 fungal genera in addition to one variety were isolated and identified for the first time from Euphorbia geniculate plants. The genus Aspergillus was the most common fungus isolated from the studied plant. The fungus Isaria feline was recorded in both leaves and stem, while Aspergillus flavus, A. ochraceus, A. terreus var. terreus, Emercilla nidulans var. acristata, Macrophomina phaseolina colonized both stem and root. The isolated fungi showed antagonistic activities against six strains of plant pathogenic fungi viz., Eupenicillium brefeldianum, Penicillium echinulatum, Alternaria phragmospora, Fusarium oxysporum, Fusarium verticilloid, and Alternaria alternata in dual culture assay. The highest antagonistic activity fungal species (Aspergillus flavus, A. fumigatus, and Fusarium lateritium) and the lowest (Cladosprium herbarum, F. culomrum, and Sporotrichum thermophile) showed twining in their secondary metabolites especially terpens and alkaloids with that of their host E. geniculata. Three concentrations of (0.5, 1.0, and 2.0 mg/ml) of these secondary metabolites extracted by ethyl acetate and n-butanol from the above six endophytic fungal species were tested against three pathogenic fungi isolated from infected tomato plant (E. brefeldianum-EBT-1, P. echinulatum-PET-2, and A. phragmospora-APT-3), whereas these pathogens showed promising sensitivity to these fungal secondary metabolites. In conclusion, this is the first report on the isolation of endophytic fungi from E. geniculata and evaluation of their antifungal activity.

Efficacy and tolerability of using platelet-rich plasma versus chemical peeling in periorbital hyperpigmentation.

BACKGROUND: Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed. OBJECTIVE: This study was designed to compare the efficacy and tolerability of autologous platelet-rich plasma (PRP) and chemical peeling in POH. SUBJECTS AND METHODS: Forty-two patients were enrolled in this study and randomly subdivided into two groups. Group A patients were assigned to receive four sessions of chemical peeling using trichloroacetic acid and lactic acid, while group B was assigned to patients who received four sessions of PRP injection with 2 weeks of intervals. Patients were assessed by digital photographs. The degree of improvement included four degrees from poor to excellent, and side effects were reported. RESULTS: Females constituted 38 out of 42 patients (mean age, 28.14 ± 3.47 years). There was a significant improvement in favor of chemical peeling over PRP. Good improvement occurred in 47.6% in the group A versus 4.8% in group B (P < 0.001). None of the PRP group had excellent improvement, while 38% of chemical peeling group did. Most of group A patients reported very pleased (47.6%) to excellent (38%) degree, in contrast to group B where 52.5% were just pleased (P < 0.001). Some of group A patients experienced itching (14.3%) and redness (14.3%), while in group B, they experienced pain (23.8%) and edema (14.3%) with nonsignificant difference between both groups (P = 0.07). CONCLUSIONS: Both PRP and chemical peeling are effective for treatment of POH; however, chemical peeling is much more effective, tolerable, and satisfying procedure than PRP.